Track topics on Twitter Track topics that are important to you
The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:
nbsp; nbsp; nbsp; Hospitals
nbsp; nbsp; nbsp; Commercial/Private Labs
nbsp; nbsp; nbsp; Physician Offices
nbsp; nbsp; nbsp; Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Influenza tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 232 pages and 15 tables
Original Article: 2017 Global Influenza Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities [Updated: 30032017] Prices from USD $4350NEXT ARTICLE
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...